MTHFD1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.627800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.415400E-01
Normal-vs-Stage2
6.933000E-01
Normal-vs-Stage3
8.758000E-01
Normal-vs-Stage4
7.879200E-01
Stage1-vs-Stage2
9.289500E-02
Stage1-vs-Stage3
5.092400E-01
Stage1-vs-Stage4
1.779220E-01
Stage2-vs-Stage3
4.946600E-01
Stage2-vs-Stage4
9.019600E-01
Stage3-vs-Stage4
6.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.671400E-01
Normal-vs-AfricanAmerican
7.723200E-01
Normal-vs-Asian
9.422400E-01
Caucasian-vs-AfricanAmerican
9.027600E-01
Caucasian-vs-Asian
5.064600E-01
AfricanAmerican-vs-Asian
6.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.616400E-01
Normal-vs-Female
7.634400E-01
Male-vs-Female
9.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.481800E-01
Normal-vs-Age(41-60Yrs)
5.465800E-01
Normal-vs-Age(61-80Yrs)
9.255800E-01
Normal-vs-Age(81-100Yrs)
4.990800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.543160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.855000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.938760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.132100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.481200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.455900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.093200E-01
Normal-vs-Daily Drinker
9.142200E-01
Normal-vs-Weekly Drinker
4.379400E-01
Normal-vs-Occasional Drinker
6.609200E-01
Normal-vs-Social Drinker
8.962200E-01
Non Drinker-vs-Daily Drinker
9.519600E-01
Non Drinker-vs-Weekly Drinker
2.088200E-01
Non Drinker-vs-Occasional Drinker
4.478000E-01
Non Drinker-vs-Social Drinker
9.324800E-01
Daily Drinker-vs-Weekly Drinker
1.602160E-01
Daily Drinker-vs-Occasional Drinker
4.083200E-01
Daily Drinker-vs-Social Drinker
9.853600E-01
Weekly Drinker-vs-Occasional Drinker
6.695400E-01
Weekly Drinker-vs-Social Drinker
1.664030E-01
Occasional Drinker-vs-Social Drinker
4.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.259200E-01
Normal-vs-Grade 2
9.123600E-01
Normal-vs-Grade 3
6.563200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.229100E-04
Grade 1-vs-Grade 3
5.571900E-04
Grade 1-vs-Grade 4
8.259200E-01
Grade 2-vs-Grade 3
3.487800E-01
Grade 2-vs-Grade 4
9.123600E-01
Grade 3-vs-Grade 4
6.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.736400E-01
Normal-vs-NonDiabetic
7.621400E-01
Diabetic-vs-NonDiabetic
9.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.347600E-01
Normal-vs-NoPancreatitis
7.663200E-01
Pancreatitis-vs-NoPancreatitis
8.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.357800E-01
Normal-vs-N1
6.671400E-01
N0-vs-N1
1.873030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.285000E-01
Normal-vs-TP53-NonMutant
5.092600E-01
TP53-Mutant-vs-TP53-NonMutant
3.481900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
